Cargando…

Identification and validation of candidate clinical signatures of apolipoprotein L isoforms in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is a lethal malignancy worldwide with an increasing number of new cases each year. Apolipoprotein (APOL) isoforms have been explored for their associations with HCC.The GSE14520 cohort was used for training data; The Cancer Genome Atlas (TCGA) database was used for val...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xiang-Kun, Guo, Yu-Xiang, Wang, Miao, Zhang, Xu-Dong, Liu, Zhong-Yuan, Wang, Mao-Sen, Luo, Kai, Huang, Shuai, Li, Ren-Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684526/ https://www.ncbi.nlm.nih.gov/pubmed/38017264 http://dx.doi.org/10.1038/s41598-023-48366-0

Ejemplares similares

Comprehensive analysis of candidate signatures of long non-coding RNA LINC01116 and related protein-coding genes in patients with hepatocellular carcinoma
por: Wang, Xiang-Kun, et al.
Publicado: (2023)

Identification and validation of a three-gene signature as a candidate prognostic biomarker for lower grade glioma
por: Xiao, Kai, et al.
Publicado: (2020)

Mechanisms and regulations of ferroptosis
por: Zhang, Xu-Dong, et al.
Publicado: (2023)

Clinical implications of RAB13 expression in pan-cancer based on multi-databases integrative analysis
por: Zhang, Xu-dong, et al.
Publicado: (2023)

Construction and Validation of a Combined Ferroptosis and Hypoxia Prognostic Signature for Hepatocellular Carcinoma
por: Wen, Kai, et al.
Publicado: (2021)

Clusterin/apolipoprotein J, its isoforms and Alzheimer's disease
por: Milinkeviciute, Giedre, et al.
Publicado: (2023)

Apolipoprotein E Isoform-specific changes related to stress and trauma exposure
por: Torres, Eileen Ruth S., et al.
Publicado: (2022)

In Vivo Human Apolipoprotein E Isoform Fractional Turnover Rates in the CNS
por: Wildsmith, Kristin R., et al.
Publicado: (2012)

Identification and validation of a prognostic four-genes signature for hepatocellular carcinoma: integrated ceRNA network analysis
por: Yan, Yongcong, et al.
Publicado: (2019)

Isoform-Specific Effects of Apolipoprotein E on Markers of Inflammation and Toxicity in Brain Glia and Neuronal Cells In Vitro
por: Iannucci, Jaclyn, et al.
Publicado: (2021)

Metalloproteins and apolipoprotein C: candidate plasma biomarkers of T2DM screened by comparative proteomics and lipidomics in ZDF rats
por: Wang, Shuai, et al.
Publicado: (2020)

Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma
por: Li, Wang, et al.
Publicado: (2020)

Identification and Validation of Ferroptosis-Related Subtypes and a Predictive Signature in Hepatocellular Carcinoma
por: Zheng, Chunlan, et al.
Publicado: (2023)

Apolipoprotein E region molecular signatures of Alzheimer's disease
por: Kulminski, Alexander M., et al.
Publicado: (2018)

Correction: In Vivo Human Apolipoprotein E Isoform Fractional Turnover Rates in the CNS
por: Wildsmith, Kristin R., et al.
Publicado: (2012)

Identification of prognostic long non-coding RNA signature with potential drugs in hepatocellular carcinoma
por: Hao, Fengjie, et al.
Publicado: (2021)

Development and Validation of a Five-RNA–Based Signature and Identification of Candidate Drugs for Neuroblastoma
por: Zhang, PeiPei, et al.
Publicado: (2021)

Astrocytic and Neuronal Apolipoprotein E Isoforms Differentially Affect Neuronal Excitability
por: Konings, Sabine C., et al.
Publicado: (2021)

Apolipoprotein A2 Isoforms: New Insight into the Risk of Myocardial Infarction
por: Hisamatsu, Takashi
Publicado: (2021)

Assessment of Apolipoprotein(a) Isoform Size Using Phenotypic and Genotypic Methods
por: Fogacci, Federica, et al.
Publicado: (2023)

Identification and validation a costimulatory molecule gene signature to predict the prognosis and immunotherapy response for hepatocellular carcinoma
por: Hu, Yinan, et al.
Publicado: (2022)

Identification and Validation of an 6-Metabolism-Related Gene Signature and Its Correlation With Immune Checkpoint in Hepatocellular Carcinoma
por: Ren, He, et al.
Publicado: (2021)

Development and Validation of an Immune-Related lncRNA Signature for Predicting the Prognosis of Hepatocellular Carcinoma
por: Kong, Weihao, et al.
Publicado: (2020)

A Novel Metabolism-Related Signature as a Candidate Prognostic Biomarker for Hepatocellular Carcinoma
por: Wang, Zhihao, et al.
Publicado: (2021)

Development and validation of a copper-related gene prognostic signature in hepatocellular carcinoma
por: Shi, Haoting, et al.
Publicado: (2023)

Identification and Validation of an Immune-related Prognostic Signature for Hepatocellular Carcinoma
por: Xia, Xinxin, et al.
Publicado: (2021)

Effects of apolipoprotein E isoform, sex, and diet on insulin BBB pharmacokinetics in mice
por: Rhea, Elizabeth M., et al.
Publicado: (2021)

Isoform-dependent lysosomal degradation and internalization of apolipoprotein E requires autophagy proteins
por: Fote, Gianna M., et al.
Publicado: (2022)

Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance
por: Shi, Ke-Qing, et al.
Publicado: (2015)

Identification and Validation of a Tumor Microenvironment-Related Gene Signature in Hepatocellular Carcinoma Prognosis
por: Huang, Changjing, et al.
Publicado: (2021)

Establishment and validation of a cholesterol metabolism-related prognostic signature for hepatocellular carcinoma
por: Tang, Linsong, et al.
Publicado: (2022)

Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma
por: Peng, Yanan, et al.
Publicado: (2021)

Identification of a Tumor Immunological Phenotype-Related Gene Signature for Predicting Prognosis, Immunotherapy Efficacy, and Drug Candidates in Hepatocellular Carcinoma
por: Tang, Yuqin, et al.
Publicado: (2022)

Development and Validation of a Propionate Metabolism-Related Gene Signature for Prognostic Prediction of Hepatocellular Carcinoma
por: Xiao, Jincheng, et al.
Publicado: (2023)

Identification and validation of immune‐related lncRNA prognostic signatures for melanoma
por: Xiao, Bo, et al.
Publicado: (2021)

Development and validation of a risk score for predicting mortality after resection of primary hepatocellular carcinoma
por: Zhou, Xiang, et al.
Publicado: (2020)

Apolipoproteins and cancer
por: Ren, Liwen, et al.
Publicado: (2019)

Developing and Validating an Autophagy Gene-Set-Based Prognostic Signature in Hepatocellular Carcinoma Patients
por: Zhang, Jie, et al.
Publicado: (2022)

Identification and Validation of Immune-Related Gene Prognostic Signature for Hepatocellular Carcinoma
por: Chen, Wenbiao, et al.
Publicado: (2020)

Identification and validation of redox-immune based prognostic signature for hepatocellular carcinoma
por: Tu, Kangsheng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_oclvlp1bo92mlqlgejo7sq5c8h